4.7 Article

CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases

Puneet Sharma et al.

OPEN BIOLOGY (2014)

Review Oncology

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

Alla Arzumanyan et al.

NATURE REVIEWS CANCER (2013)

Review Biochemistry & Molecular Biology

Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma: A Systematic Review

Naoshi Nishida et al.

CURRENT GENOMICS (2011)

Article Biochemistry & Molecular Biology

Cullin-4A.DNA Damage-binding Protein 1 E3 Ligase Complex Targets Tumor Suppressor RASSF1A for Degradation during Mitosis

Lingyan Jiang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Cullin 4B Protein Ubiquitin Ligase Targets Peroxiredoxin III for Degradation

Xi Li et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Cell Biology

Cul4A is an oncogene in malignant pleural mesothelioma

Ming-Szu Hung et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)

Review Gastroenterology & Hepatology

Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis

Morris Sherman

SEMINARS IN LIVER DISEASE (2010)

Article Biochemistry & Molecular Biology

Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression

J. Du et al.

CELL DEATH AND DIFFERENTIATION (2009)

Review Oncology

Epithelial-mesenchymal transition in hepatocellular carcinoma

Franziska van Zijl et al.

FUTURE ONCOLOGY (2009)

Review Gastroenterology & Hepatology

Molecular Mechanisms of Hepatocellular Carcinoma

Rajagopal N. Aravalli et al.

HEPATOLOGY (2008)

Article Immunology

Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax

Xiaohong Liang et al.

JOURNAL OF IMMUNOLOGY (2007)

Article Obstetrics & Gynecology

Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: Another viewpoint

S Kamoi et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2002)